The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy

J Surg Oncol. 2011 Nov 1;104(6):585-91. doi: 10.1002/jso.21919. Epub 2011 Jun 21.

Abstract

Background and objectives: The correlation between perioperative CEA, CA 19-9, and CA 72-4 and recurrence of gastric cancer has not been clarified. The aim of this study was to investigate the relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence of gastric cancer.

Methods: We retrospectively analyzed the relationships between the tumor markers CEA, CA 19-9, and CA 72-4 and recurrence of gastric cancer.

Results: In patients with early gastric cancer, the recurrence sensitivity of postoperative CEA, CA 19-9, and CA 72-4 was 40.0, 5.6, and 2.8%, respectively. And in patients with advanced gastric cancer, the recurrence sensitivity of postoperative CEA, CA 19-9, and CA 72-4 was 100.0, 68.2, and 51.3%, respectively. Multivariate analyses showed that an increase in postoperative CEA in early gastric cancer was an independent prognostic factor of recurrence. In patients with advanced gastric cancer, age >60 years, stage III, and postoperative CEA increase and CA 72-4 increase were independent prognostic factors of recurrence.

Conclusions: For patients with advanced gastric cancer, CEA, CA 19-9, and CA 72-4 are considered useful for follow-up tests. Although, CEA is considered useful for follow-up test for patients with early gastric cancer, but CA19-9 and CA72-4 are less useful due to their low sensitivity.

MeSH terms

  • Adenocarcinoma / metabolism
  • Adenocarcinoma / surgery*
  • Antigens, Tumor-Associated, Carbohydrate / metabolism*
  • Biomarkers, Tumor / metabolism*
  • CA-19-9 Antigen / metabolism*
  • Carcinoembryonic Antigen / metabolism*
  • Female
  • Follow-Up Studies
  • Gastrectomy*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local / metabolism
  • Neoplasm Recurrence, Local / surgery*
  • Perioperative Care
  • Prognosis
  • Radioimmunoassay
  • Retrospective Studies
  • Risk Factors
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / surgery*

Substances

  • Antigens, Tumor-Associated, Carbohydrate
  • Biomarkers, Tumor
  • CA-19-9 Antigen
  • CA-72-4 antigen
  • Carcinoembryonic Antigen